Search
forLearn
1 / 1 resultsResearch
5 / 79 resultsresearch BH12 Efficacy and Safety of Hair Gloss Treatments: A Systematic Review of Licensed Products in the UK
Licensed hair gloss products improve shine and smoothness but require stricter regulation to ensure safety.
research The Importance of Laser Protection Supervisors in Clinical Settings
Clinics using lasers should have trained laser safety supervisors to reduce accidents and possibly lower insurance costs.
research Implementation of the JCCP Premises Standards for Cosmetic Interventions
The JCCP's Premises Standards aim to make non-surgical cosmetic treatments safer and higher quality.
research Manifesto for Change: Governance and Regulation Within the Aesthetics Industry
The JCCP wants new rules for the UK aesthetics industry to improve safety and standards.
research Five Years After Keogh's Review of Regulation in the Aesthetics Sector, What Has Changed?
Some improvements in the aesthetics sector have been made, but patient protection is still lacking due to no compulsory register for practitioners and non-prescription dermal fillers.
Community Join
5 / 7 resultscommunity COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men
Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.
community Possible Finasteride ban happening soon
Concerns about a potential finasteride ban in the EU, possibly affecting the US, are discussed. Users doubt a ban, citing its widespread use and suggest alternatives like minoxidil and dutasteride.
community Blaming Finasteride doesn't help you solve anything: dry eyes
Finasteride is debated for causing dry eyes, with some users experiencing relief after stopping it, while others find no connection. Topical treatments like dutasteride and minoxidil are suggested as alternatives, with advice to consult medical professionals.
community Finasteride is save in the eu (they concluded the investigation)
Finasteride and dutasteride are still available in the EU, with a warning about potential suicidal thoughts. The benefits of these treatments are deemed greater than the risks.
community Common hair-loss drug consistently associated with higher rates of psychiatric harm
Finasteride and dutasteride can cause psychiatric side effects like depression and suicidal thoughts in some users, especially those with a history of mental health issues. While some users experience positive hair growth results, others face severe psychological effects, raising concerns about their safety and the need for careful monitoring.